Bayer

Bayer, headquartered in Germany and operating in the Pharmaceutical Preparation Manufacturing industry, reported a total of approximately 11.89 billion kg CO2e in Scope 1, 2, and 3 emissions for the year 2025. This figure comprises approximately 1.89 billion kg CO2e from Scope 1 emissions and approximately 0.9 billion kg CO2e from Scope 2 emissions (market-based). Scope 3 emissions were reported at approximately 9.1 billion kg CO2e, with purchased goods and services being the largest contributor at approximately 6.25 billion kg CO2e.

In 2024, Bayer's total emissions were approximately 11.78 billion kg CO2e, with Scope 1 at approximately 1.88 billion kg CO2e and Scope 2 at approximately 1.08 billion kg CO2e (market-based). Scope 3 emissions for 2024 amounted to approximately 8.82 billion kg CO2e.

Bayer has established a long-term target to achieve net-zero emissions across its entire value chain by 2050. To support this, the company has set near-term goals, including a commitment to reduce its own Scope 1 and Scope 2 greenhouse gas emissions by 42% by the end of 2029, using 2019 as the baseline year. Furthermore, Bayer aims to reduce its Scope 3 greenhouse gas emissions by 25% by 2029, a target revalidated by the Science Based Targets initiative (SBTi). Earlier targets included a 20% reduction in own emissions (Scope 1 and 2) by 2024, relative to the 2019 baseline. Bayer also aims to enable its farming customers to reduce their greenhouse gas emissions per kilogram of crop produced by 30% by 2030.